E.C. Eringa
-
Duijvelaar, E., Pan, X., Bogaard, H. J., Eringa, E. C., & Aman, J. (2024). Imatinib treatment improves hyperglycaemic dysregulation in severe COVID-19: a secondary analysis of blood biomarkers in a randomised controlled trial. Critical Care, 28(1), Article 65. https://doi.org/10.1186/s13054-024-04829-yMore information about this publication
-
Woudstra, J., Feenstra, R. G. T., Vink, C. E. M., Marques, K. M. J., Boerhout, C. K. M., de Jong, E. A. M., de Waard, G. A., van de Hoef, T. P., Chamuleau, S. A. J., Eringa, E. C., Piek, J. J., Appelman, Y., & Beijk, M. A. M. (2024). Comparison of the Diagnostic Yield of Intracoronary Acetylcholine Infusion and Acetylcholine Bolus Injection Protocols During Invasive Coronary Function Testing. American Journal of Cardiology, 217, 49-58. https://doi.org/10.1016/j.amjcard.2024.01.038More information about this publication
-
Canto, E. D., van Deursen, L., Hoek, A. G., Elders, P. J. M., den Ruijter, H. M., van der Velden, J., van Empel, V., Serné, E. H., Eringa, E. C., & Beulens, J. W. J. (2023). Microvascular endothelial dysfunction in skin is associated with higher risk of heart failure with preserved ejection fraction in women with type 2 diabetes: the Hoorn Diabetes Care System Cohort. Cardiovascular Diabetology, 22(1), Article 234. https://doi.org/10.1186/s12933-023-01935-zMore information about this publication
-
Feenstra, R. G. T., Woudstra, J., Bijloo, I., Vink, C. E. M., Boerhout, C. K. M., de Waard, G. A., Wittekoek, M. E., de Winter, R. J., Marques, K. M. J., Eringa, E. C., van de Hoef, T. P., Beijk, M. A. M., Appelman, Y., & Piek, J. J. (2023). Post-spastic flow recovery time to document vasospasm induced ischemia during acetylcholine provocation testing. IJC Heart and Vasculature, 47(1), Article 101220. https://doi.org/10.1016/j.ijcha.2023.101220More information about this publication
-
Woudstra, J., Vink, C. E. M., Schipaanboord, D. J. M., Eringa, E. C., den Ruijter, H. M., Feenstra, R. G. T., Boerhout, C. K. M., Beijk, M. A. M., de Waard, G. A., Ong, P., Seitz, A., Sechtem, U., Piek, J. J., van de Hoef, T. P., & Appelman, Y. (2023). Meta-analysis and systematic review of coronary vasospasm in ANOCA patients: Prevalence, clinical features and prognosis. Frontiers in Cardiovascular Medicine, 10(1), Article 1129159. https://doi.org/10.3389/fcvm.2023.1129159More information about this publication
-
Habibe, J. J., Boulund, U., Clemente-Olivo, M. P., de Vries, C. J. M., Eringa, E. C., Nieuwdorp, M., Ferwerda, B., Zwinderman, K., van den Born, B. J. H., Galenkamp, H., & van Raalte, D. H. (2023). FHL2 Genetic Polymorphisms and Pro-Diabetogenic Lipid Profile in the Multiethnic HELIUS Cohort. International Journal of Molecular Sciences, 24(5), Article 4332. https://doi.org/10.3390/ijms24054332More information about this publication
-
Habibe, J. J., Clemente-Olivo, M. P., Scheithauer, T. P. M., Rampanelli, E., Herrema, H., Vos, M., Mieremet, A., Nieuwdorp, M., van Raalte, D. H., Eringa, E. C., & de Vries, C. J. M. (2022). Glucose-mediated insulin secretion is improved in FHL2-deficient mice and elevated FHL2 expression in humans is associated with type 2 diabetes. Diabetologia, 65(10), 1721-1733. Article s00125-022-05750-1. https://doi.org/10.1007/s00125-022-05750-1More information about this publication
-
Feenstra, R. G. T., Boerhout, C. K. M., Vink, C. E. M., Woudstra, J., Wittekoek, M. E., de Waard, G. A., Appelman, Y., Eringa, E. C., Marques, K. M. J., de Winter, R. J., van de Hoef, T. P., Beijk, M. A. M., & Piek, J. J. (2022). Haemodynamic characterisation of different endotypes in coronary artery vasospasm in reaction to acetylcholine. IJC Heart and Vasculature, 42, Article 101105. https://doi.org/10.1016/j.ijcha.2022.101105More information about this publication
-
Feenstra, R. G. T., Boerhout, C. K. M., Woudstra, J., Vink, C. E. M., Wittekoek, M. E., de Waard, G. A., Appelman, Y., Eringa, E. C., Marques, K. M. J., de Winter, R. J., Beijk, M. A. M., van de Hoef, T. P., & Piek, J. J. (2022). Presence of Coronary Endothelial Dysfunction, Coronary Vasospasm, and Adenosine-Mediated Vasodilatory Disorders in Patients With Ischemia and Nonobstructive Coronary Arteries. Circulation-Cardiovascular Interventions, 15(8), Article 012017. https://doi.org/10.1161/CIRCINTERVENTIONS.122.012017More information about this publication
-
Kane, J., Jansen, M., Hendrix, S., Bosmans, L. A., Beckers, L., van Tiel, C., Gijbels, M., Zelcer, N., de Vries, C. J., von Hundelshausen, P., Vervloet, M., Eringa, E., Horrevoets, A., van Royen, N., & Lutgens, E. (2022). Anti-Galectin-2 antibody treatment reduces atherosclerotic plaque size and alters macrophage polarity. Thrombosis and Haemostasis, 122(06), 1047-1057. https://doi.org/10.1055/a-1711-1055More information about this publication
E.C. Eringa
Associate Professor
Fysiologie
School for Cardiovascular Diseases
Fac. Health, Medicine and Life Sciences